Narrative review / 2024
Authors contend that new antiobesity medications and lifestyle-based behavioral approaches are complementary and must coexist.
This perspective addresses whether new antiobesity medications, such as glucagon-like peptide-1 receptor agonists, render lifestyle-based obesity treatments obsolete. The authors argue that medical approaches affect physiologic pathways that support behavioral treatment success, while behavioral approaches address weight loss-adjacent outcomes not affected by medication. Consequently, they conclude that medical and behavioral approaches are complementary and must coexist to address the obesity epidemic.
- Study type
- Perspective article
- Who was studied
- Individuals with obesity
- What was measured
- Complementary roles of antiobesity medications and behavioral approaches
THE PAPER
Game changers: do new medications make lifestyle-based treatment of obesity obsolete?
Lewis KH, Moore JB, Ard JD. Obesity (Silver Spring), 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.